March 16, 2021
RFA-HL-22-007 - Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Clinical Centers (Collaborative UG3/UH3 Clinical Trial Required)
RFA-HL-22-008 - Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center (U24 Clinical Trial Required)
National Heart, Lung, and Blood Institute (NHLBI)
The National Heart, Lung, and Blood Institute (NHLBI) issued Funding Opportunity Announcements (FOAs) on February 22, 2021 for RFA-HL-22-007 "Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Clinical Centers (Collaborative UG3/UH3 Clinical Trial Required)" and RFA-HL-22-008 "Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center (U24 Clinical Trial Required)".
This Notice provides information regarding an upcoming Pre-Application webinar to inform potential applicants about RFA-HL-22-007 and RFA-22-008. This will include a review of the purpose and objectives of the FOAs, application and peer review requirements, and budget considerations.
Webinar Information:
Date: Monday, April 12, 2021
Time: 12:00 pm Eastern Standard Time (EST)
All interested individuals must register in advance to participate in the webinar via Zoom.
All prospective applicants are invited to attend the webinar and are strongly encouraged to send relevant questions prior to the webinar to maximize the use of time. Questions should be sent by email to nhlbi_enrich@nih.gov by April 5, 2021. These questions will be prioritized during the Q&A portion of the webinar. While an effort will be made to include all questions in the webinar, it is possible that not all questions will be addressed during the event due to time constraints.
Participation in this webinar, although encouraged, is optional and is not required for FOA submission. A recording of the webinar will not be posted online.
More information about the ENRICH program, including Frequently Asked Questions (FAQs) is available here. Applicants are strongly encouraged to review the FAQs, which may be updated at any time without additional notice, prior to submitting their application.
Scientific/Research Contact(s)
Charlotte A. Pratt, PhD, MS, RD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0382
Email: prattc@mail.nih.gov
Elizabeth Neilson, PhD, MPH, MSN
Office of Disease Prevention (ODP)
Telephone: 301-827-5578
Email: neilsone@mail.nih.gov
Jamie White, MS
Office Of Research On Women's Health (ORWH)
Phone:301-402-1770
E-mail: jamie.white@nih.gov
Priscah Mujuru, DrPH, MPH, RN
National Institute on Minority Health and Health Disparities (NIMHD)
Phone: 301-594-9765
E-mail: mujurup@mail.nih.gov
Monique Fountain Hanna, MD, MPH, MBA
Health Resources and Services Administration
Division of Home Visiting and Early Childhood Systems
Phone:215-861-4393
E-mail: mfountain@hrsa.gov
Nancy Geyelin Margie, PhD
Administration for Children and Families
Office of Planning, Research, and Evaluation
Division of Family Strengthening
Phone: 202-401-5522
E-mail: nancy.margie@acf.hhs.gov
Kyle Peplinski, MA
Health Resources and Services Administration
Division of Home Visiting and Early Childhood Systems
Phone:(301) 443-7758
E-mail: kpeplinski@hrsa.gov
Peer Review Contact
Yingying Li-Smerin, MD, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Email: NHLBIChiefReviewBranch@mail.nih.gov
Financial/Grants Management Contact
Allison Moyal
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8036
Email: moyala@mail.nih.gov